| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis
|
Bartelink, Imke H
|
|
2016
|
3 |
11 |
p. e526-e536
nvt p.
|
article
|
| 2 |
Can we not bleed?
|
The Lancet Haematology,
|
|
2016
|
3 |
11 |
p. e497-
1 p.
|
article
|
| 3 |
Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy
|
Joly, Bérangère S
|
|
2016
|
3 |
11 |
p. e537-e546
nvt p.
|
article
|
| 4 |
Definition of functional iron deficiency and intravenous iron supplementation
|
Eisenga, Michele F
|
|
2016
|
3 |
11 |
p. e504-
1 p.
|
article
|
| 5 |
Definition of functional iron deficiency and intravenous iron supplementation – Author's reply
|
Khalafallah, Alhossain A
|
|
2016
|
3 |
11 |
p. e504-e505
nvt p.
|
article
|
| 6 |
Gilbert's syndrome in haemopoietic cell transplantation
|
Arora, Mukta
|
|
2016
|
3 |
11 |
p. e500-e501
nvt p.
|
article
|
| 7 |
Mortality outcomes after busulfan-containing conditioning treatment and haemopoietic cell transplantation in patients with Gilbert's syndrome: a retrospective cohort study
|
McDonald, George B
|
|
2016
|
3 |
11 |
p. e516-e525
nvt p.
|
article
|
| 8 |
Overall survival of patients with relapsed multiple myeloma treated with panobinostat or placebo plus bortezomib and dexamethasone (the PANORAMA 1 trial): a randomised, placebo-controlled, phase 3 trial
|
San-Miguel, Jesús F
|
|
2016
|
3 |
11 |
p. e506-e515
nvt p.
|
article
|
| 9 |
Panobinostat plus bortezomib and dexamethasone for relapsed myeloma
|
Pratt, Guy
|
|
2016
|
3 |
11 |
p. e498-e499
nvt p.
|
article
|
| 10 |
Standardising busulfan dosage for children and young adults
|
Gorin, Norbert-Claude
|
|
2016
|
3 |
11 |
p. e502-e503
nvt p.
|
article
|
Journal description